title: Tropomyosin-induced arthritis in rats.
abstract: OBJECTIVE
  Immunization of rats with alpha-tropomyosin (TPM) led to arthritis, uveitis and dermatitis, typical features of Behçet's disease (BD). The present study characterizes the arthritic features of this animal model, not previously described.
  
  
  METHODS
  Lewis rats were immunized with bovine alpha-TPM and another group of rats was treated with neutralizing anti- tumor necrosis factor-alpha (TNF-alpha) antibodies.
  
  
  RESULTS
  Clinically more than 90% of the immunized rats developed severe acute arthritis 12 days after vaccination. Rats that were followed-up for 6 months had persistent inflammation of the leg joints. Histologic studies demonstrated predominant mononuclear infiltrations in the acute phase of arthritis; the chronic arthritic process resulted in cartilage and bone damage and abundant fibrosis which led to joint deformations. Male and female rats had a similar clinical course. Analysis of the splenocyte cytokine profile kinetics revealed a persistently high level of interferon-gamma (INF-gamma) and an increase in TNF-alpha secretion during the acute phase. Increasing levels of interleukin (IL)-10 heralded the decline in clinical arthritis. No IL-4 was detected. No arthritis was detected in the rats treated with anti-TNF-alpha antibodies.
  
  
  CONCLUSIONS
  The data indicates that alpha-TPM serves as an autoantigen to induce acute and chronic destructive arthritis in rats. This model is a TNF-alpha dependent autoimmune disease, with a Th1 cytokine profile.
authors.affiliation: Department of Medicine B, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Baharav
authors.forename: F
authors.initials: F
authors.lastname: Mor
authors.forename: M
authors.initials: M
authors.lastname: Halpern
authors.forename: F
authors.initials: F
authors.lastname: Quintana
authors.forename: A
authors.initials: A
authors.lastname: Weinberger
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D001169:Arthritis, Experimental / Q000139:chemically induced* / Q000473:pathology; D001528:Behcet Syndrome / Q000139:chemically induced* / Q000473:pathology*; D004195:Disease Models, Animal; D009124:Muscle Proteins / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D012720:Severity of Illness Index; D014033:Toe Joint / Q000473:pathology; D014335:Tropomyosin / Q000494:pharmacology*
chemical_list: D000276:Adjuvants, Immunologic; D009124:Muscle Proteins; D014335:Tropomyosin